ALX vs DLR

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a concerning lack of Altman Z-Score due to insufficient data. Despite strong profitability metrics like high ROE and gross margin, the company faces significant risks including an extremely high debt/equity ratio of 7.86, negative earnings growth, and a dangerously high payout ratio of 252.10%, which raises sustainability concerns. The stock is trading at $243.04, far above both the Graham Number ($63.22) and intrinsic value estimate ($49.49), suggesting severe overvaluation. While recent price performance has been strong over the past year, weak fundamentals and deteriorating growth trends point to elevated downside risk.

DLR presents a concerning divergence between market price and fundamental value, anchored by a stable but mediocre Piotroski F-Score of 4/9. While revenue growth is robust at 17.1%, the company is experiencing a severe earnings collapse (-53.4% YoY) and an unsustainable dividend payout ratio of 136.31%. The stock trades at a massive premium to its Graham Number ($72.14) and Intrinsic Value ($25.06), with a PEG ratio of 19.01 signaling extreme overvaluation. Despite analyst 'Buy' recommendations, the deterministic data suggests the current price is driven by sector hype rather than financial performance.